Volume 30, Number 3—March 2024
Dispatch
Biphasic MERS-CoV Incidence in Nomadic Dromedaries with Putative Transmission to Humans, Kenya, 2022–2023
Table
Region | MERS-CoV RNA–positive samples/total samples (%) | Town of origin | MERS-CoV RNA–positive samples/total samples (%) |
|
---|---|---|---|---|
Female camels | Male camels | |||
Isiolo | 15/859 (1.75) | Burat | 1/252 (0.4) | 10/326 (3.1) |
Bulla Pesa | 0/2 | 0/0 | ||
Kinna | 0/13 | 1/19 (5.3) | ||
Oldo/Nyiro | 0/2 | 2/23 (8.7) | ||
Garbatulla | 0/1 | 0/1 | ||
Ngare Mara |
0/106 |
0/114 |
||
Marsabit | 26/1,846 (1.41) | Laisamis | 1/250 (0.4) | 21/1,591 (1.3) |
Marsabit Central | 0/0 | 0/1 | ||
Sololo | 0/1 | 0/0 | ||
North Horr | 0/0 | 0/2 | ||
not defined |
0/0 |
0/1 |
||
Samburu |
0/6 (0) |
Wamba East |
0/0 |
0/6 |
Total | 36/2,711 (1.3) | 2/627 (0.3) | 34/2,084 (1.6) |
*MERS-CoV, Middle East respiratory syndrome coronavirus.
1These authors contributed equally to this article.
Page created: January 15, 2024
Page updated: February 22, 2024
Page reviewed: February 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.